Hardware, Equipment & Parts
Compare Stocks
2 / 10Stock Comparison
NOVT vs IPGP
Revenue, margins, valuation, and 5-year total return — side by side.
Semiconductors
NOVT vs IPGP — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Hardware, Equipment & Parts | Semiconductors |
| Market Cap | $4.86B | $4.31B |
| Revenue (TTM) | $981M | $1.04B |
| Net Income (TTM) | $54M | $29M |
| Gross Margin | 44.4% | 37.6% |
| Operating Margin | 11.9% | 0.3% |
| Forward P/E | 38.2x | 62.6x |
| Total Debt | $342M | $0.00 |
| Cash & Equiv. | $381M | $404M |
NOVT vs IPGP — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Novanta Inc. (NOVT) | 100 | 132.7 | +32.7% |
| IPG Photonics Corpo… (IPGP) | 100 | 65.4 | -34.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: NOVT vs IPGP
Each card shows where this stock fits in a portfolio — not just who wins on paper.
NOVT carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 3.3%, EPS growth -16.9%, 3Y rev CAGR 4.4%
- 8.5% 10Y total return vs IPGP's 20.2%
- 3.3% revenue growth vs IPGP's 2.7%
IPGP is the clearest fit if your priority is income & stability and sleep-well-at-night.
- Dividend streak 1 yrs, beta 1.80
- Lower volatility, beta 1.80, current ratio 6.08x
- Beta 1.80, current ratio 6.08x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 3.3% revenue growth vs IPGP's 2.7% | |
| Value | Lower P/E (38.2x vs 62.6x) | |
| Quality / Margins | 5.5% margin vs IPGP's 2.8% | |
| Stability / Safety | Beta 1.80 vs NOVT's 2.02 | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | +75.6% vs NOVT's +14.6% | |
| Efficiency (ROA) | 3.0% ROA vs IPGP's 1.2%, ROIC 7.4% vs 0.6% |
NOVT vs IPGP — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
NOVT vs IPGP — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
NOVT leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
IPGP and NOVT operate at a comparable scale, with $1.0B and $981M in trailing revenue. Profitability is closely matched — net margins range from 5.5% (NOVT) to 2.8% (IPGP). On growth, IPGP holds the edge at +16.6% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $981M | $1.0B |
| EBITDAEarnings before interest/tax | $179M | $55M |
| Net IncomeAfter-tax profit | $54M | $29M |
| Free Cash FlowCash after capex | $48M | $8M |
| Gross MarginGross profit ÷ Revenue | +44.4% | +37.6% |
| Operating MarginEBIT ÷ Revenue | +11.9% | +0.3% |
| Net MarginNet income ÷ Revenue | +5.5% | +2.8% |
| FCF MarginFCF ÷ Revenue | +4.9% | +0.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | +8.5% | +16.6% |
| EPS Growth (YoY)Latest quarter vs prior year | -2.2% | -54.4% |
Valuation Metrics
NOVT leads this category, winning 3 of 5 comparable metrics.
Valuation Metrics
At 92.7x trailing earnings, NOVT trades at a 33% valuation discount to IPGP's 139.2x P/E. On an enterprise value basis, NOVT's 27.0x EV/EBITDA is more attractive than IPGP's 48.9x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $4.9B | $4.3B |
| Enterprise ValueMkt cap + debt − cash | $4.8B | $3.9B |
| Trailing P/EPrice ÷ TTM EPS | 92.71x | 139.22x |
| Forward P/EPrice ÷ next-FY EPS est. | 38.25x | 62.62x |
| PEG RatioP/E ÷ EPS growth rate | 28.13x | — |
| EV / EBITDAEnterprise value multiple | 27.00x | 48.90x |
| Price / SalesMarket cap ÷ Revenue | 4.96x | 4.30x |
| Price / BookPrice ÷ Book value/share | 3.81x | 2.04x |
| Price / FCFMarket cap ÷ FCF | 100.38x | — |
Profitability & Efficiency
NOVT leads this category, winning 4 of 7 comparable metrics.
Profitability & Efficiency
NOVT delivers a 4.1% return on equity — every $100 of shareholder capital generates $4 in annual profit, vs $1 for IPGP. On the Piotroski fundamental quality scale (0–9), IPGP scores 6/9 vs NOVT's 5/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +4.1% | +1.4% |
| ROA (TTM)Return on assets | +3.0% | +1.2% |
| ROICReturn on invested capital | +7.4% | +0.6% |
| ROCEReturn on capital employed | +8.3% | +0.6% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 6 |
| Debt / EquityFinancial leverage | 0.26x | — |
| Net DebtTotal debt minus cash | -$39M | -$404M |
| Cash & Equiv.Liquid assets | $381M | $404M |
| Total DebtShort + long-term debt | $342M | $0 |
| Interest CoverageEBIT ÷ Interest expense | 4.89x | — |
Total Returns (Dividends Reinvested)
IPGP leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in NOVT five years ago would be worth $10,573 today (with dividends reinvested), compared to $5,151 for IPGP. Over the past 12 months, IPGP leads with a +75.6% total return vs NOVT's +14.6%. The 3-year compound annual growth rate (CAGR) favors IPGP at -4.4% vs NOVT's -5.3% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +22.6% | +35.8% |
| 1-Year ReturnPast 12 months | +14.6% | +75.6% |
| 3-Year ReturnCumulative with dividends | -15.2% | -12.7% |
| 5-Year ReturnCumulative with dividends | +5.7% | -48.5% |
| 10-Year ReturnCumulative with dividends | +853.7% | +20.2% |
| CAGR (3Y)Annualised 3-year return | -5.3% | -4.4% |
Risk & Volatility
Evenly matched — NOVT and IPGP each lead in 1 of 2 comparable metrics.
Risk & Volatility
IPGP is the less volatile stock with a 1.80 beta — it tends to amplify market swings less than NOVT's 2.02 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NOVT currently trades 90.9% from its 52-week high vs IPGP's 65.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.02x | 1.80x |
| 52-Week HighHighest price in past year | $149.95 | $155.82 |
| 52-Week LowLowest price in past year | $98.27 | $53.98 |
| % of 52W HighCurrent price vs 52-week peak | +90.9% | +65.2% |
| RSI (14)Momentum oscillator 0–100 | 62.6 | 39.7 |
| Avg Volume (50D)Average daily shares traded | 375K | 510K |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates NOVT as "Buy" and IPGP as "Buy". Consensus price targets imply 49.2% upside for IPGP (target: $152) vs 10.1% for NOVT (target: $150).
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $150.00 | $151.67 |
| # AnalystsCovering analysts | 3 | 27 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | 1 |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +0.8% | +1.3% |
NOVT leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). IPGP leads in 1 (Total Returns). 1 tied.
NOVT vs IPGP: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is NOVT or IPGP a better buy right now?
For growth investors, Novanta Inc.
(NOVT) is the stronger pick with 3. 3% revenue growth year-over-year, versus 2. 7% for IPG Photonics Corporation (IPGP). Novanta Inc. (NOVT) offers the better valuation at 92. 7x trailing P/E (38. 2x forward), making it the more compelling value choice. Analysts rate Novanta Inc. (NOVT) a "Buy" — based on 3 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — NOVT or IPGP?
On trailing P/E, Novanta Inc.
(NOVT) is the cheapest at 92. 7x versus IPG Photonics Corporation at 139. 2x. On forward P/E, Novanta Inc. is actually cheaper at 38. 2x.
03Which is the better long-term investment — NOVT or IPGP?
Over the past 5 years, Novanta Inc.
(NOVT) delivered a total return of +5. 7%, compared to -48. 5% for IPG Photonics Corporation (IPGP). Over 10 years, the gap is even starker: NOVT returned +853. 7% versus IPGP's +20. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — NOVT or IPGP?
By beta (market sensitivity over 5 years), IPG Photonics Corporation (IPGP) is the lower-risk stock at 1.
80β versus Novanta Inc. 's 2. 02β — meaning NOVT is approximately 12% more volatile than IPGP relative to the S&P 500.
05Which is growing faster — NOVT or IPGP?
By revenue growth (latest reported year), Novanta Inc.
(NOVT) is pulling ahead at 3. 3% versus 2. 7% for IPG Photonics Corporation (IPGP). On earnings-per-share growth, the picture is similar: IPG Photonics Corporation grew EPS 117. 8% year-over-year, compared to -16. 9% for Novanta Inc.. Over a 3-year CAGR, NOVT leads at 4. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — NOVT or IPGP?
Novanta Inc.
(NOVT) is the more profitable company, earning 5. 5% net margin versus 3. 1% for IPG Photonics Corporation — meaning it keeps 5. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NOVT leads at 11. 9% versus 1. 3% for IPGP. At the gross margin level — before operating expenses — NOVT leads at 44. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is NOVT or IPGP more undervalued right now?
On forward earnings alone, Novanta Inc.
(NOVT) trades at 38. 2x forward P/E versus 62. 6x for IPG Photonics Corporation — 24. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for IPGP: 49. 2% to $151. 67.
08Which pays a better dividend — NOVT or IPGP?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is NOVT or IPGP better for a retirement portfolio?
For long-horizon retirement investors, Novanta Inc.
(NOVT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+853. 7% 10Y return). IPG Photonics Corporation (IPGP) carries a higher beta of 1. 80 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (NOVT: +853. 7%, IPGP: +20. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between NOVT and IPGP?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.